AbbVie Inc. (ABBV)
NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
At close: 04:03PM EDT
After hours:
Currency in USD
Valuation measures4
| Market cap (intra-day) | 237.30B |
| Enterprise value | 300.27B |
| Trailing P/E | 18.98 |
| Forward P/E | 11.51 |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 4.16 |
| Price/book (mrq) | 16.19 |
| Enterprise value/revenue | 5.24 |
| Enterprise value/EBITDA | 12.22 |
Trading information
Stock price history
| Beta (5Y monthly) | 0.69 |
| 52-week change 3 | 29.88% |
| S&P500 52-week change 3 | -13.12% |
| 52-week high 3 | 175.91 |
| 52-week low 3 | 106.86 |
| 50-day moving average 3 | 140.88 |
| 200-day moving average 3 | 146.38 |
Share statistics
| Avg vol (3-month) 3 | 5.55M |
| Avg vol (10-day) 3 | 6.84M |
| Shares outstanding 5 | 1.77B |
| Implied shares outstanding 6 | N/A |
| Float 8 | 1.77B |
| % held by insiders 1 | 0.11% |
| % held by institutions 1 | 70.75% |
| Shares short (14 Sept 2022) 4 | 12.95M |
| Short ratio (14 Sept 2022) 4 | 2.93 |
| Short % of float (14 Sept 2022) 4 | 0.73% |
| Short % of shares outstanding (14 Sept 2022) 4 | 0.73% |
| Shares short (prior month 14 Aug 2022) 4 | 13.01M |
Dividends & splits
| Forward annual dividend rate 4 | 5.64 |
| Forward annual dividend yield 4 | 4.20% |
| Trailing annual dividend rate 3 | 5.53 |
| Trailing annual dividend yield 3 | 4.00% |
| 5-year average dividend yield 4 | 4.31 |
| Payout ratio 4 | 76.66% |
| Dividend date 3 | 14 Nov 2022 |
| Ex-dividend date 4 | 12 Oct 2022 |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Fiscal year
| Fiscal year ends | 30 Dec 2021 |
| Most-recent quarter (mrq) | 29 June 2022 |
Profitability
| Profit margin | 22.03% |
| Operating margin (ttm) | 33.06% |
Management effectiveness
| Return on assets (ttm) | 8.14% |
| Return on equity (ttm) | 92.71% |
Income statement
| Revenue (ttm) | 57.35B |
| Revenue per share (ttm) | 32.39 |
| Quarterly revenue growth (yoy) | 4.50% |
| Gross profit (ttm) | 38.88B |
| EBITDA | 27.17B |
| Net income avi to common (ttm) | 12.57B |
| Diluted EPS (ttm) | 7.07 |
| Quarterly earnings growth (yoy) | 20.60% |
Balance sheet
| Total cash (mrq) | 9.96B |
| Total cash per share (mrq) | 5.64 |
| Total debt (mrq) | 73.19B |
| Total debt/equity (mrq) | 498.28 |
| Current ratio (mrq) | 0.84 |
| Book value per share (mrq) | 8.29 |
Cash flow statement
| Operating cash flow (ttm) | 22.92B |
| Levered free cash flow (ttm) | 18.63B |
© 2022 Yahoo. All rights reserved.
